Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
413.84
214.72
411.72
339.00
264.53
146.65
298.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
413.84
214.72
411.72
339.00
264.53
146.65
298.38
Raw Material Cost
132.47
68.16
144.23
100.85
72.66
51.41
92.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.81
8.11
3.51
12.14
13.25
13.92
13.60
Selling and Distribution Expenses
184.05
131.58
202.04
166.56
142.43
103.05
246.98
Other Expenses
6.69
4.99
7.13
4.98
4.83
4.46
12.05
Total Expenditure (Excl Depreciation)
390.26
257.73
421.04
329.32
276.66
212.94
473.33
Operating Profit (PBDIT) excl Other Income
23.599999999999998
-43
-9.3
9.7
-12.1
-66.3
-175
Other Income
27.01
17.13
48.85
40.04
37.76
64.45
69.03
Operating Profit (PBDIT)
96.78
24.72
70.16
91.77
56.13
38.21
-101.83
Interest
6.81
8.11
3.51
12.14
13.25
13.92
13.60
Exceptional Items
12.47
3.29
-0.42
2.22
-0.68
2.89
1.13
Gross Profit (PBDT)
281.37
146.56
267.49
238.15
191.87
95.24
206.13
Depreciation
56.27
55.16
51.45
51.25
44.72
44.31
53.30
Profit Before Tax
46.19
-35.26
14.78
30.61
-2.52
-17.14
-167.60
Tax
0.82
6.82
-0.20
-0.15
-0.83
-5.40
1.05
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.70
-45.62
14.73
30.51
-2.09
-12.34
-169.22
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.70
-45.62
14.73
30.51
-2.09
-12.34
-169.22
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
45.70
-45.62
14.73
30.51
-2.09
-12.34
-169.22
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.16
1.13
1.11
1.09
1.1
1.07
1.06
Reserves
5,753.02
5,590.43
5,517.41
5,389.93
5,371.81
5,255.86
5,225.14
Earnings per share (EPS)
0.18
-0.18
0.06
0.12
-0.01
-0.05
-0.68
Diluted Earnings per share
0.18
-0.18
0.06
0.12
-0.01
-0.05
-0.68
Operating Profit Margin (Excl OI)
3.26%
-22.15%
-7.32%
0.14%
-9.96%
-48.11%
-75.13%
Gross Profit Margin
24.76%
9.27%
16.09%
24.15%
15.95%
18.53%
-38.31%
PAT Margin
11.04%
-21.24%
3.58%
9.0%
-0.79%
-8.42%
-56.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 92.73% vs -47.85% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 200.22% vs -410.20% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 818.42% vs -64.32% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -16.05% vs 131.43% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of CanSino Biologics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
413.84
0
413.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
413.84
0
413.84
Raw Material Cost
132.47
0
132.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.81
0
6.81
Selling and Distribution Expenses
184.05
0
184.05
Other Expenses
6.69
0.00
6.69
Total Expenditure (Excl Depreciation)
390.26
0
390.26
Operating Profit (PBDIT) excl Other Income
23.58
0.00
23.58
Other Income
27.01
0
27.01
Operating Profit (PBDIT)
96.78
0
96.78
Interest
6.81
0
6.81
Exceptional Items
12.47
0
12.47
Gross Profit (PBDT)
281.37
0
281.37
Depreciation
56.27
0
56.27
Profit Before Tax
46.19
0
46.19
Tax
0.82
0
0.82
Provisions and contingencies
0
0
0.00
Profit After Tax
45.70
0
45.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
45.70
0
45.70
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.70
0
45.70
Equity Capital
0
0
0.00
Face Value
1.16
0
0.00
Reserves
5,753.02
0
5,753.02
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
3.26%
0%
0.00
3.26%
Gross Profit Margin
24.76%
0%
0.00
24.76%
PAT Margin
11.04%
0%
0.00
11.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 41.38 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 92.73% vs -47.85% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 56.45% vs 29.53% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.57 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 200.22% vs -410.20% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2,276.19% vs 96.48% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.98 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 818.42% vs -64.32% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 279.35% vs 202.79% in Jun 2025
Quarterly - Interest
Interest 0.68 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -16.05% vs 131.43% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -48.48% vs -32.31% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.26%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
